Singapore, though conscious of its limitations, has been able to leverage its key assets of location, infrastructure and local talent in order to…

Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies must be amenable to outside…

France provides a unique environment for dermo-cosmetics companies such as Pierre Fabre, Uriage, and Galderma to thrive in terms of the industry's…

The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant…

The Mexican pharmaceutical market’s capacity to change dramatically in a short period of time means that both innovators and generics companies must…

Switzerland’s pharma industry is moving beyond staid conservatism and embracing risk in order to compete internationally and foster a new culture of…

After a number of years of difficulty post-2008 and the euro-debt crisis, Ireland’s pharma manufacturing industry and economy in general is now…

Since gaining independence in 1965, Singapore has invested heavily in moving beyond being a mere supplier of low cost labor like many of its Asian…

Digitalization, a hot topic throughout the healthcare and life sciences industry, is having a major effect in Italy through more personalized home…

Smaller pharma companies in Hungary are looking to new unconventional methods of OTC promotion to sidestep the country's somewhat restrictive…

Chronic underfinancing is a common pitfall for many former socialist states and Hungary is no exception.  Total health spending ultimately…

Pharmaceuticals do not appear in pharmacies and hospitals out of nowhere, yet the logistics of transporting these goods are a seldom acknowledged…